Literature DB >> 14771042

Observations on serological epidemiology antibodies to the Lansing strain of poliomyelitis virus in sera from Alaskan eskimos.

J R PAUL, J R RIORDAN.   

Abstract

Entities:  

Keywords:  POLIOMYELITIS

Mesh:

Substances:

Year:  1950        PMID: 14771042

Source DB:  PubMed          Journal:  Am J Hyg        ISSN: 0096-5294


× No keyword cloud information.
  9 in total

1.  Present status of the problem of vaccination against poliomyelitis.

Authors:  J E SALK
Journal:  Am J Public Health Nations Health       Date:  1955-03

2.  The present status of oral vaccination against poliomyelitis and future problems.

Authors:  C E VAN ROOYEN; R L OZERE
Journal:  Can Med Assoc J       Date:  1960-04-09       Impact factor: 8.262

3.  Acute intestinal disease in the Arctic.

Authors:  J E GORDON; F L BABBOTT
Journal:  Am J Public Health Nations Health       Date:  1959-11

4.  Poliomyelitis antibodies in sera from the Netherlands, Curacao, Suriname, St. Eustatius and Netherlands New-Guinea.

Authors:  B HOFMAN; J B WILTERDINK
Journal:  Antonie Van Leeuwenhoek       Date:  1960       Impact factor: 2.271

5.  Poliomyelitis survey in Rio de Janeiro.

Authors:  M M DA SILVA; J T SYVERTON
Journal:  Public Health Rep       Date:  1956-04       Impact factor: 2.792

6.  Paralytic consequences of poliomyelitis infection in different parts of the world and in different population groups.

Authors:  A B SABIN
Journal:  Am J Public Health Nations Health       Date:  1951-10

7.  Coxsackie virus infections in Southern Africa.

Authors:  J GEAR
Journal:  Yale J Biol Med       Date:  1961 Dec-1962 Feb

8.  Complement-fixing antibodies to type 2 (Lansing) poliomyelitis virus in a normal population of a subtropical area.

Authors:  N GOLDBLUM; J L MELNICK
Journal:  J Exp Med       Date:  1952-08       Impact factor: 14.307

9.  Historical and geographical aspects of the epidemiology of poliomyelitis.

Authors:  J R PAUL
Journal:  Yale J Biol Med       Date:  1954-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.